Protagenic Therapeutics, Inc.\new (PTIX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: -$120.6K2014: -$121.4K2015: -$667.2K2016: $2.48M2017: $1.22M2018: -$210.9K2019: -$634.4K2020: -$1.15M2021: $9.94M2022: $6.92M2023: $3.67M2024: $1.01M$1.01M
2013Shareholders' Equity (USD)2024
Fiscal YearShareholders' EquityChange YoY
2024$1.01M-72.4%
2023$3.67M-47.0%
2022$6.92M-30.4%
2021$9.94M+964.7%
2020-$1.15M-81.2%
2019-$634.4K-200.8%
2018-$210.9K-117.3%
2017$1.22M-50.8%
2016$2.48M+471.3%
2015-$667.2K-449.8%
2014-$121.4K-0.6%
2013-$120.6K